Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmalink makes board appointments

This article was originally published in Scrip

Executive Summary

The privately held Swedish speciality pharmaceutical company Pharmalink has appointed Anders Wiklund and Dr Jens Christensen to its board of directors. Mr Wiklund has been an advisor to the biotechnology industry since 1997, when he founded Wiklund International. Dr Kristensen is vice-president of clinical development at the Swedish drug development company KaroBio. In addition, Dr Lennart Hansson, director of the life sciences business area at Industrifonden, an independent foundation founded in 1979, joins Pharmalink's board as the Industrifonden representative. Dr Hansson, who has experience in the life science sector having worked at KabiGen, Symbicom, AstraZeneca, Arexis, Biovitrum and Karolinska Development, replaces retiring board member Professor Jörgen Lönngren.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts